Laser-assisted phototherapy clears AK in immunocompromised patients

05/28/2013 | SkinAndAllergyNews.com

Intensified ablative fractional laser-assisted photodynamic therapy cleared actinic keratoses and warty lesions on the hands of organ-transplant recipients better than blative fractional laser therapy alone in a randomized clinical trial. Ablative fractional laser-assisted photodynamic therapy was painful and caused intense inflammation in 30% of patients, but completely cleared 73% of all actinic keratoses and 37% of all wartlike lesions, compared with 31% and 14% respectively, for ablative fractional laser alone.

View Full Article in:

SkinAndAllergyNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY